257 related articles for article (PubMed ID: 21418814)
21. Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys.
Rigouts L; Hoza AS; De Rijk P; Torrea G; Chonde TM; Basra D; Zignol M; van Leth F; Egwaga SM; Van Deun A
Int J Tuberc Lung Dis; 2011 Jul; 15(7):959-65. PubMed ID: 21682972
[TBL] [Abstract][Full Text] [Related]
22. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Nimri L; Samara H; Batchoun R
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
[TBL] [Abstract][Full Text] [Related]
23. Feasibility and cost analysis of programmatic implementation of Microscopic-Observation Drug Susceptibility (MODS) assay in Nigeria.
Ochang EA; Oduyebo OO; Onwuezobe IA; Collier D; Bode-Sojobi I; Odo M
Niger J Med; 2016; 25(3):226-33. PubMed ID: 30011167
[TBL] [Abstract][Full Text] [Related]
24. Rapid purity check method for susceptibility testing of M. tuberculosis complex with the MGIT 960 system.
Huang TS; Liu YC; Tu HZ; Sy CL; Chen YS; Chen BC
Ann Clin Lab Sci; 2007; 37(4):323-9. PubMed ID: 18000288
[TBL] [Abstract][Full Text] [Related]
25. Drug resistance in Mycobacterium tuberculosis isolates from tuberculosis patients in Kerala, India.
Joseph BV; Soman S; Radhakrishnan I; Madhavilatha GK; Paul LK; Mundayoor S; Kumar RA
Int J Tuberc Lung Dis; 2009 Apr; 13(4):494-9. PubMed ID: 19335956
[TBL] [Abstract][Full Text] [Related]
26. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis.
Arias M; Mello FC; Pavón A; Marsico AG; Alvarado-Gálvez C; Rosales S; Pessôa CL; Pérez M; Andrade MK; Kritski AL; Fonseca LS; Chaisson RE; Kimerling ME; Dorman SE
Clin Infect Dis; 2007 Mar; 44(5):674-80. PubMed ID: 17278058
[TBL] [Abstract][Full Text] [Related]
28. Drug resistance to the first line of antitubercular regimen (a preliminary report).
Varaiya A; Gogate A
Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
[TBL] [Abstract][Full Text] [Related]
29. Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples.
Musa HR; Ambroggi M; Souto A; Angeby KA
J Clin Microbiol; 2005 Jul; 43(7):3159-61. PubMed ID: 16000429
[TBL] [Abstract][Full Text] [Related]
30. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
[TBL] [Abstract][Full Text] [Related]
31. The value of microscopic-observation drug susceptibility assay in the diagnosis of tuberculosis and detection of multidrug resistance.
Sertel Şelale D; Uzun M
APMIS; 2018 Jan; 126(1):38-44. PubMed ID: 29154391
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide.
Ghiraldi LD; Campanerut PA; Spositto FL; Sato DN; Leite CQ; Hirata M; Hirata RD; Cardoso RF
Clin Microbiol Infect; 2011 Dec; 17(12):1792-7. PubMed ID: 21595790
[TBL] [Abstract][Full Text] [Related]
33. Drug susceptibility pattern of Mycobacterium tuberculosis isolates against conventional anti-tuberculosis drugs in Dhaka, Bangladesh.
Mottalib A; Hossain M; Khalil I; Islam S; Hossain A
Saudi Med J; 2011 May; 32(5):484-8. PubMed ID: 21556469
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of MODS assay for rapid detection of Mycobacterium tuberculosis resistance to second-line drugs in a tertiary care tuberculosis hospital in China.
Huang Z; Li G; Chen J; Li W; Xu X; Luo Q; Xiong G; Sun J; Li J
Tuberculosis (Edinb); 2014 Sep; 94(5):506-10. PubMed ID: 25082461
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis].
Gui XH; Xu P; Zhao M; Wang LL; Wu J; Li J; Gao Q; Mei J
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):43-5. PubMed ID: 20368024
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of the BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis isolates compared with the proportion method on solid media].
Abe C; Aono A; Hirano K
Kekkaku; 2001 Oct; 76(10):657-62. PubMed ID: 11712386
[TBL] [Abstract][Full Text] [Related]
37. [Improvement of routine works and quality control in mycobacterial laboratory].
Suzuki K; Higuchi T
Kekkaku; 2007 Mar; 82(3):217-27. PubMed ID: 17444126
[TBL] [Abstract][Full Text] [Related]
38. Direct Susceptibility Testing on MGIT 960 TB System: A Rapid Method for Detection of Drug Resistant Tuberculosis.
Tayyab N; Zaman G; Satti L; Ikram A; Gardezi AH; Khadim MT
J Coll Physicians Surg Pak; 2018 Aug; 28(8):590-593. PubMed ID: 30060785
[TBL] [Abstract][Full Text] [Related]
39. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
Kobayashi I; Abe C; Mitarai S
Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.
Krüüner A; Yates MD; Drobniewski FA
J Clin Microbiol; 2006 Mar; 44(3):811-8. PubMed ID: 16517859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
